445 related articles for article (PubMed ID: 19202116)
1. Use of continuous intravenous ketamine for end-stage cancer pain in children.
Conway M; White N; Jean CS; Zempsky WT; Steven K
J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
[TBL] [Abstract][Full Text] [Related]
2. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
Tsui BC; Davies D; Desai S; Malherbe S
J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
[TBL] [Abstract][Full Text] [Related]
3. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
4. The use of ketamine as adjuvant therapy to control severe pain.
Campbell-Fleming JM; Williams A
Clin J Oncol Nurs; 2008 Feb; 12(1):102-7. PubMed ID: 18258579
[TBL] [Abstract][Full Text] [Related]
5. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.
Sen S; Aydin ON; Aydin K
Pain Med; 2006; 7(2):166-9. PubMed ID: 16634730
[TBL] [Abstract][Full Text] [Related]
7. Chronic administration of ketamine for analgesia.
Ben-Ari A; Lewis MC; Davidson E
J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
[TBL] [Abstract][Full Text] [Related]
8. Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
Fine PG
J Pain Symptom Manage; 1999 Apr; 17(4):296-300. PubMed ID: 10203883
[TBL] [Abstract][Full Text] [Related]
9. Successful use of ketamine infusion in the treatment of intractable cancer pain in an outpatient.
Chung WJ; Pharo GH
J Pain Symptom Manage; 2007 Jan; 33(1):2-5. PubMed ID: 17196899
[No Abstract] [Full Text] [Related]
10. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
Amin P; Roeland E; Atayee R
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
Elsewaisy O; Slon B; Monagle J
Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
[TBL] [Abstract][Full Text] [Related]
12. The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series.
Kerr C; Holahan T; Milch R
J Palliat Med; 2011 Sep; 14(9):1074-7. PubMed ID: 21838517
[TBL] [Abstract][Full Text] [Related]
13. Adjunct continuous intravenous ketamine infusion for postoperative pain relief following posterior spinal instrumentation for correction of scoliosis: a case report.
Tsui BC; Wagner A; Mahood J; Moreau M
Paediatr Anaesth; 2007 Apr; 17(4):383-6. PubMed ID: 17359410
[TBL] [Abstract][Full Text] [Related]
14. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
Mercadante S; Arcuri E; Ferrera P; Villari P; Mangione S
J Pain Symptom Manage; 2005 Nov; 30(5):485-91. PubMed ID: 16310622
[TBL] [Abstract][Full Text] [Related]
15. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
Kong PE; Snijdelaar DG; Crul BJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
[TBL] [Abstract][Full Text] [Related]
16. Pain management in fulminating ulcerative colitis.
White M; Shah N; Lindley K; Lloyd-Thomas A; Thomas M
Paediatr Anaesth; 2006 Nov; 16(11):1148-52. PubMed ID: 17040304
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of an intravenous ketamine infusion in a child with significant burns.
White MC; Karsli C
Paediatr Anaesth; 2007 Nov; 17(11):1102-4. PubMed ID: 17897278
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient.
Clark JL; Kalan GE
J Pain Symptom Manage; 1995 May; 10(4):310-4. PubMed ID: 7541437
[TBL] [Abstract][Full Text] [Related]
19. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain.
Kajiume T; Sera Y; Nakanuno R; Ogura T; Karakawa S; Kobayakawa M; Taguchi S; Oshita K; Kawaguchi H; Sato T; Kobayashi M
J Palliat Med; 2012 Jun; 15(6):719-22. PubMed ID: 22401313
[TBL] [Abstract][Full Text] [Related]
20. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
Kapural L; Kapural M; Bensitel T; Sessler DI
Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
